Addus HomeCare Q3 Earnings Call Highlights
Addus HomeCare (ADUS) reported Q3 revenue of $389.7M, with personal care services generating $301M (77.6%). Same-store personal care revenue grew 6.9% YoY. The company expects to improve EBITDA margins through synergies from the AccentCare acquisition. Addus plans to fund the acquisition with cash and revolving credit. Hospice revenue rose 4.1%, and home health revenue increased 2.5%. Management anticipates modest EBITDA margin decline in 2027 due to the AccentCare deal.
How this was made
The 30-second read
Why it matters
The earnings release provides fresh data on revenue mix and profitability, influencing short‑term price action.
Market read
Earnings beat and margin guidance may drive modest upside for ADUS and related home‑care stocks.
What to watch
Potential headwinds from slower census growth in Texas and Illinois could temper future growth.
Background
Addus HomeCare reported Q3 results, highlighting personal‑care revenue, margin expansion, and upcoming Medicare hospice reimbursement updates.
Ticker impact
Q3 earnings call disclosed personal care revenue, margin expansion, and guidance for FY 2027, providing fresh financial metrics.
likely modest upside as investors price in higher EBITDA margin and cash‑rich balance sheet.
New EBITDA margin of 13.2% vs 12.5% prior year and guidance for 13% FY margin indicate operational leverage.
Market effects
Personal‑care and hospice providers may see valuation lifts on margin guidance.
U.S. home‑care sector gains modest support.
Limited to U.S. healthcare services investors.
Counterpoint
Margin guidance may be optimistic given upcoming rate pressures in key states.
Key entities
- CompanyAddus HomeCare Inc.
U.S. provider of in‑home personal care, hospice, and home health services.
